Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BBBD with Methotrexate, Carboplatin, and Trastuzumab for Breast Cancer Brain Metastases
NCT00397501Phase 2Withdrawn
- Sponsor
- OHSU Knight Cancer Institute
- Start
- Oct 2013
- Primary completion
- Oct 2013
- Modality
- Antibody Conjugates, Monoclonal Antibodies, DNA Intercalators/Alkylators
01
Overview
A Phase 2 trial of carboplatin, methotrexate, trastuzumab in breast cancer, brain metastasis (BM), sponsored by OHSU Knight Cancer Institute. Planned start Oct 2013; status: withdrawn.
02
Drugs
03
Conditions
breast cancerbrain metastasis (BM)
Beyond the preview
Go deeper on NCT00397501.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00397501.